Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about ...

“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Vulnerable premature babies needing extra protection against RSV will receive a long-lasting single injection of nirsevimab, ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

A single shot during pregnancy is proving to be a powerful shield for newborns against one of the most common and dangerous viruses for infants: RSV. In a new UK study, babies whose mothers received t ...

Respiratory syncytial virus (RSV) infections in older adults lead to significantly more severe health outcomes and long-term cardiovascular complications compared to other common causes of ...

Adults over 50 and those with chronic conditions are at risk too. Learn how to protect yourself and where to go for more information.

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

July is Chronic Disease Awareness Month and serves as an important reminder to take charge of your health and get informed about potential health risks.